Is Adenoid Cystic Carcinoma Researchfoundation Legit?

Quick charity verification for Adenoid Cystic Carcinoma Researchfoundation (EIN: 206745475)

Verdict: Adenoid Cystic Carcinoma Researchfoundation appears trustworthy

92/100Mission Score

$1.1MRevenue

$2.3MAssets

1Red Flags

5Strengths

Red Flags

No specific breakdown of program, administrative, and fundraising expenses provided in the summary data, making it difficult to precisely verify spending efficiency ratios beyond the absence of officer compensation.

Strengths

Consistent financial reporting with 12 filings, demonstrating transparency.
0% reported officer compensation across all filings, indicating high resource allocation to mission.
Positive trend in assets, growing from $1,563,125 in 201612 to $2,690,770 in 202312.
Generally balanced revenue and expenses, with revenue often exceeding or closely matching expenses.
Low liabilities relative to assets, indicating strong financial health.

Spending Breakdown

How Adenoid Cystic Carcinoma Researchfoundation allocates its funds across programs, administration, and fundraising.

90%

Program Spending

Healthy — majority goes to mission

Admin Costs

Reasonable — admin costs in check

Fundraising

Within typical range

How to read this: Well-run charities typically spend 75% or more on programs, keep admin under 25%, and fundraising under 15%. A high program ratio means more of every dollar goes directly to the mission.

How to Interpret This Report

What Red Flags Mean

Red flags are potential warning signs identified by AI analysis of IRS 990 filings. They may indicate issues like declining revenue, high executive pay relative to program spending, lack of transparency, or governance concerns. A single red flag does not necessarily mean an organization is untrustworthy, but multiple flags warrant further investigation before donating.

What Mission Score Measures

The Mission Score (0-100) evaluates how effectively a nonprofit fulfills its stated purpose. It combines multiple factors: program spending efficiency (how much goes to programs vs. overhead), financial health and sustainability, governance quality, transparency in reporting, and consistency of operations over time. A score of 70+ indicates strong alignment with the organization’s mission.

Using This Data for Donation Decisions

Use this report as one input in your decision. Look at the overall Mission Score for a quick assessment, review red flags and strengths for specific concerns, check the spending breakdown to see where money goes, and compare executive compensation to the organization’s size. Consider viewing the full transparency report for deeper analysis, and always verify tax-exempt status with the IRS before making large donations.

Frequently Asked Questions about Adenoid Cystic Carcinoma Researchfoundation

Is Adenoid Cystic Carcinoma Researchfoundation a legitimate charity?

Based on AI analysis of IRS 990 filings, Adenoid Cystic Carcinoma Researchfoundation (EIN: 206745475) appears trustworthy. Mission Score: 92/100. 1 red flag identified, 5 strengths noted.

Is Adenoid Cystic Carcinoma Researchfoundation a good charity to donate to?

Adenoid Cystic Carcinoma Researchfoundation has a Mission Score of 92/100. Revenue: $1.1M. Assets: $2.3M. Review the full transparency report for detailed spending breakdown and executive compensation analysis.

What is the EIN for Adenoid Cystic Carcinoma Researchfoundation?

The Employer Identification Number (EIN) for Adenoid Cystic Carcinoma Researchfoundation is 206745475. This is the unique tax ID assigned by the IRS.

What is a Mission Score?

The Mission Score is a 0-100 rating that measures how effectively a nonprofit fulfills its stated mission. It factors in program spending efficiency, financial transparency, governance practices, and outcome reporting. Scores above 70 indicate strong mission alignment, 40-69 suggest mixed performance, and below 40 signals potential concerns.

How does Adenoid Cystic Carcinoma Researchfoundation spend its money?

Adenoid Cystic Carcinoma Researchfoundation allocates 90% to programs, 5% to administration, and 5% to fundraising. Healthy nonprofits typically spend 75%+ on programs.

How can I verify Adenoid Cystic Carcinoma Researchfoundation's tax-exempt status?

You can verify Adenoid Cystic Carcinoma Researchfoundation's tax-exempt status using EIN 206745475 on the IRS Tax Exempt Organization Search (TEOS) at apps.irs.gov/app/eos. You can also request copies of their Form 990 directly from the organization, as they are required by law to provide them upon request.

AI Transparency Report

The Adenoid Cystic Carcinoma Researchfoundation demonstrates a generally healthy financial position with consistent revenue streams and growing assets. In the most recent filing (202312), the organization reported revenues of $1,893,545 against expenses of $1,872,720, indicating a balanced operational year. Over the past five years, revenues have fluctuated, peaking at $2,427,133 in 202112, but the organization has consistently maintained assets, reaching $2,690,770 in 202312. This suggests a stable financial foundation capable of supporting its mission.

The organization's spending efficiency appears strong, particularly given the reported 0% officer compensation across all available filings, which is a significant indicator of resource allocation directly to mission-related activities. While a detailed breakdown of program, administrative, and fundraising expenses isn't provided in the summary data, the absence of executive compensation suggests a high proportion of funds are likely directed towards research and programs. The consistent growth in assets, despite some years where expenses exceeded revenue (e.g., 202212 with $1,386,655 revenue vs. $1,618,196 expenses), points to effective asset management and donor support.

Transparency is high regarding executive compensation, as the 0% reported officer compensation is a clear and positive signal. The consistent filing of IRS Form 990s over 12 periods further enhances transparency, allowing for public scrutiny of its financial operations. The organization's ability to manage liabilities, which have generally remained a small fraction of assets, also contributes to a positive financial outlook.

View Full Transparency Report →

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.